期刊文献+

供者干细胞动员中诱发肺泡出血1例并文献复习 被引量:1

A case of alveolar hemorrhage from non-related donor of allogeneic hematopoietic stem cell transplantation and literature review
原文传递
导出
摘要 干细胞采集这一技术自1992年我国造血干细胞捐献者资料库建立以来,已经形成了较为成熟、安全的技术体系,HLA相合无关供者是目前异基因造血干细胞移植中干细胞的主要来源之一,在造血干细胞动员过程中,有少部分健康供者在接受重组人粒细胞集落刺激因子(granulocyte colony-stimulating factors,G-CSF)后会出现相关不良反应,但大部分症状轻微、持续时间较短,无需特殊干预可自行缓解。 To investigate the diagnosis and treatment of adverse events during the mobilization of allogeneic donor hematopoietic stem cells,we reported a case of alveolar hemorrhage during hematopoietic stem cell mobilization.The occurrence of pulmonary hemorrhage in the process of stem cell mobilization was highly correlated with granulocyte colony stimulating factor.It's needed to exclude other causes what lead pulmonary hemorrhage,and treat patients with glucocorticoid as soon as possible.
作者 田雨露 张孝平 陈宝安 葛峥 高冲 金楠 TIAN Yulu;ZHANG Xiaoping;CHEN Baofan
出处 《临床血液学杂志》 CAS 2019年第6期893-895,共3页 Journal of Clinical Hematology
基金 江苏省医学重点学科(No:ZDXKB2016020) 江苏省自然科学基金青年基金项目(No:BK 20150639)
关键词 肺出血 急性呼吸窘迫综合征 造血干细胞移植 pulmonary hemorrhage acute respiratory distress syndrome hematopoietic stem cell transplantation
  • 相关文献

参考文献1

二级参考文献21

  • 1Tigue CC, McKoy JM, Evens AM, et al. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. 2007;40(3):185-192.
  • 2de la Rubia J, de Arriba F, Arbona C, et al. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica. 2008; 93(5):735-740.
  • 3Cesaro S, Marson P, Gazzola MV, et al. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation. Haematologica. 2002;87(8 Suppl):35-41.
  • 4Michael A, Chitphakdithai P, Miller JP, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604-3611.
  • 5Demuynck H, Zachée P, Verhoef GE, et al. Risks of rhG-CSF treatment in drug-induced agranulocytosis. Ann Hematol. 1995; 70(3):143-147.
  • 6Arimura K, Inoue H, Kukita T, et al. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica. 2005;90(3):27-29.
  • 7Deeren DH, Zachee P, Malbrain ML. Granulocyte colony-stimulating factor-induced capillary leak syndrome confirmed by extravascular lung water measurements. Ann Hematol. 2005;84(2):89-94.
  • 8Hasegawa Y, Ninomiya H, Kamoshita M, et al. Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma. Intern Med. 1997;36(5):360-364.
  • 9Katoh M, Shikoshi K, Takada M, et al. Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor. Ann Hematol. 1993;67(4):201-202.
  • 10Niitsu N, Iki S, Muroi K, et al. Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96. Br J Cancer. 1997; 76(12): 1661-1666.

共引文献1

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部